Skip to content
Telehealth Graded
State guide

New Mexico Medicaid and weight-loss drugs

New Mexico does pay for medication to treat obesity, which already makes it unusual. What it pays for is the older pharmacy: appetite suppressants and orlistat, authorized above a body mass index of 40, or 35 with a risk factor, for an initial three months. The three drugs most people mean when they say weight-loss medication sit in the other column of the same table. Meanwhile the state spent 2026 standing up its first statewide preferred drug list, and that list does not reach this class at all.

Every source on this page was read first-hand in September 2026, and each one below carries the date printed on the document itself.

3
documents cited
7
sourced facts
2
primary sources

What changed, and what the document says

  1. The covered column exists

    Covered

    Most state programs in this tier begin from a refusal. This one begins from a qualified yes, and the qualification is which drugs.

    Some weight loss medications for treating obesity are covered under the New Mexico Medicaid Fee-for-Service program with prior authorization.

    New Mexico Health Care Authority, Medical Assistance DivisionMarch 4, 2025

  2. And so does the other one

    Not covered

    Setmelanotide, liraglutide, semaglutide and tirzepatide are the four entries under this heading. The table is the whole finding.

    Not Covered by New Mexico Medicaid

    New Mexico Health Care Authority, Medical Assistance DivisionMarch 4, 2025

  3. The threshold for the drugs that are covered

    Conditions apply

    A body mass index gate with a named comorbidity list, printed as the first of two criteria.

    BMI >40 or BMI > 35 with additional risk factors (hypertension, diabetes, dyslipidemia), and

    New Mexico Health Care Authority, Medical Assistance DivisionMarch 4, 2025

  4. What is not demanded

    Covered

    The diet-and-exercise trial that several states in this tier make mandatory is explicitly optional here.

    A six-month trial of caloric restriction and exercise is recommended (not required).

    New Mexico Health Care Authority, Medical Assistance DivisionMarch 4, 2025

  5. How long an approval lasts

    Conditions apply

    The clock is short, and only two of the covered drugs have a published route to a longer renewal.

    Authorization is for an initial three-month period.

    New Mexico Health Care Authority, Medical Assistance DivisionMarch 4, 2025

  6. The statewide list that arrived in 2026

    Context

    New Mexico's first statewide preferred drug list took effect in July 2026, and it is deliberately partial — the weight-reduction table above is still the document that answers this question.

    HCA PDL only includes select drug classes

    New Mexico Health Care AuthorityEffective: July 1, 2026

  7. What the legislature was told about the trend

    Context

    Legislative staff briefed a committee that this drug class has rearranged the program's own top-spend table.

    GLP-1 drugs have shifted the composition of top Medicaid drugs.

    New Mexico Legislative Finance CommitteeNovember 2025

Which of these companies serve New Mexico?

Of the 257 companies we grade, 25 publish a list of the states they are licensed in. We checked 229 more and found no such list on any page we read; 3 we have not checked either way.

16 of those lists name New Mexico: Gala Health, Care Bare Rx, Vita Bella, TelePeptide, Wisp, WePeptideRx, Ways2Well, TeleClinic, Tyde Wellness, The Virtual NP, Trimi, Enhance MD, HumeCare+, Rx.com, Mojoon and Peak Wellness. That is a licensure claim each company makes about itself, not something we checked with a state board.

A published list is a starting point, not a guarantee. If availability decides your choice, ask before you pay and get the answer in writing.

Sources

Each document below was fetched and read on the date shown beside it, which is the date printed on the document — not always the date in its web address. All of them were read in September 2026, the same session as the rest of this page.

Nothing on this page is medical advice, and nobody here is a clinician. Coverage rules change; check the linked document before you rely on it.